Laura Chico
Wedbush | Healthcare
Laura Chico is an analyst from Wedbush specializing in the Healthcare sector. Ranked #121 out of 4358 analysts, they have issued 33 stock ratings with a success rate of 90.49% and an average return of 72.38%.
Laura Chico has a well-established track record, with 33 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 90.49% and an average return of 72.38%, underscoring their expertise and ability to identify winning opportunities for investors.
Recent Ratings Analysis
ATXS
HoldOct 15, 2025
Target
$13.00
Current
$12.09
Performance
1.43%
Laura Chico rated ATXS as Neutral on Oct 15, 2025, setting a price target of 13. The Hold stance appears justified, as shares hovered around 12.09 with a 1.43% move.
PEPG
BuySep 30, 2025
Target
$8.00
Current
$4.80
Performance
3.90%
On Sep 30, 2025, PEPG was given a Outperform rating by Laura Chico, with a target price of 8. The stock traded sideways with a 3.90% move, keeping the bullish thesis unresolved.
LRMR
BuySep 30, 2025
Target
$11.00
Current
$4.26
Performance
31.89%
LRMR received a Outperform rating from Laura Chico on Sep 30, 2025, aiming for 11. Momentum has favored the Buy call, with shares climbing from 4.26 to 4.26, rewarding those who trusted the recommendation.
DNTH
BuySep 12, 2025
Target
$44.00
Current
$36.00
Performance
-3.12%
On Sep 12, 2025, Laura Chico published a Outperform outlook on DNTH, with a target of 44. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 36.
TRML
HoldSep 09, 2025
Target
$48.00
Current
$47.90
Performance
0.55%
Laura Chico on Sep 09, 2025 assigned TRML a Neutral rating, with a price target of 48. The Hold stance reflected consolidation, as shares held near 47.9.
JBIO
BuyAug 14, 2025
Target
$18.00
Current
$9.79
Performance
44.53%
On Aug 14, 2025, Laura Chico reaffirmed JBIO with a Outperform rating, targeting 18. The recommendation was supported by strong follow-through as the stock rose from 9.785 to 9.785.
SLDB
BuyAug 13, 2025
Target
$14.00
Current
$6.16
Performance
-7.78%
SLDB was rated Outperform by Laura Chico on Aug 13, 2025, with a price objective of 14. This case shows how bullish projections can fail, with the stock now below 6.16.
STOK
BuyAug 13, 2025
Target
$22.00
Current
$34.17
Performance
102.07%
On Aug 13, 2025, Laura Chico initiated coverage on STOK with a Outperform rating and target of 22. The stock’s climb of 102.07% since the call highlights the foresight in the rating.
XENE
BuyAug 12, 2025
Target
$43.00
Current
$42.17
Performance
17.17%
Laura Chico issued a Outperform recommendation for XENE on Aug 12, 2025, price target set at 43. Investors following the Buy call captured upside momentum, with shares now at 42.17.
TVTX
BuyAug 07, 2025
Target
$32.00
Current
$27.51
Performance
62.68%
On Aug 07, 2025, TVTX was evaluated by Laura Chico, who gave a Outperform rating and target of 32. This case illustrates how a timely bullish rating can translate into tangible gains of 62.68%.
GOSS
BuyAug 06, 2025
Target
$5.00
Current
$2.31
Performance
16.67%
Laura Chico rated GOSS as Outperform on Aug 06, 2025, setting a price target of 5. The call has proven timely, with shares rising 16.67% toward the price target of 5.
ARDX
BuyAug 05, 2025
Target
$14.00
Current
$5.05
Performance
-1.56%
On Aug 05, 2025, ARDX was given a Outperform rating by Laura Chico, with a target price of 14. The stock traded sideways with a -1.56% move, keeping the bullish thesis unresolved.
NBIX
BuyJul 31, 2025
Target
$141.00
Current
$137.52
Performance
7.24%
NBIX received a Outperform rating from Laura Chico on Jul 31, 2025, aiming for 141. Momentum has favored the Buy call, with shares climbing from 137.52 to 137.52, rewarding those who trusted the recommendation.
RARE
HoldJul 14, 2025
Target
$34.00
Current
$33.97
Performance
16.22%
On Jul 14, 2025, Laura Chico published a Neutral outlook on RARE, with a target of 34. The Hold call missed some of the bullish momentum as shares advanced toward 34.
MAZE
BuyJul 08, 2025
Target
$17.00
Current
$28.45
Performance
88.91%
Laura Chico on Jul 08, 2025 assigned MAZE a Outperform rating, with a price target of 17. The Buy call aligned well with market performance, producing a gain of 88.91%.
BCRX
BuyJun 30, 2025
Target
$18.00
Current
$6.72
Performance
-25.00%
On Jun 30, 2025, Laura Chico reaffirmed BCRX with a Outperform rating, targeting 18. Shares slid 25.00% despite the recommendation, highlighting downside risks.
LEN
HoldJun 18, 2025
Target
$130.00
Current
$122.87
Performance
18.82%
LEN was rated Neutral by Laura Chico on Jun 18, 2025, with a price objective of 130. Despite caution, upside momentum rewarded risk-takers with gains to 122.87.
VIGL
BuyMar 14, 2025
Target
$13.00
Current
$8.05
Performance
298.51%
On Mar 14, 2025, Laura Chico initiated coverage on VIGL with a Outperform rating and target of 13. The stock’s climb of 298.51% since the call highlights the foresight in the rating.
OVID
BuyMar 12, 2025
Target
$3.00
Current
$1.57
Performance
214.00%
Laura Chico issued a Outperform recommendation for OVID on Mar 12, 2025, price target set at 3. Investors following the Buy call captured upside momentum, with shares now at 1.57.
APLS
HoldMar 03, 2025
Target
$29.00
Current
$24.15
Performance
0.37%
On Mar 03, 2025, APLS was evaluated by Laura Chico, who gave a Neutral rating and target of 29. Hold sentiment was validated by subdued trading with no breakout beyond 24.15.
SAGE
HoldFeb 12, 2025
Target
$6.00
Current
$8.68
Performance
21.23%
Laura Chico rated SAGE as Neutral on Feb 12, 2025, setting a price target of 6. Despite the Hold call, shares climbed 21.23% to 8.68, revealing unexpected momentum.
BIIB
HoldSep 23, 2024
Target
$205.00
Current
$142.26
Performance
-27.35%
On Sep 23, 2024, BIIB was given a Neutral rating by Laura Chico, with a target price of 205. The rating provided protection from downside risk as the stock fell to 142.26.
LBPH
BuySep 17, 2024
Target
$44.00
Current
$59.98
Performance
117.48%
LBPH received a Outperform rating from Laura Chico on Sep 17, 2024, aiming for 44. Momentum has favored the Buy call, with shares climbing from 59.98 to 59.98, rewarding those who trusted the recommendation.
ANRO
BuySep 03, 2024
Target
$29.00
Current
$5.88
Performance
-55.45%
On Sep 03, 2024, Laura Chico published a Outperform outlook on ANRO, with a target of 29. Market action contradicted the Buy thesis, as shares slipped to 5.88.
EWTX
BuyAug 16, 2024
Target
$31.00
Current
$15.32
Performance
-16.96%
Laura Chico on Aug 16, 2024 assigned EWTX a Outperform rating, with a price target of 31. The call has struggled to gain traction, with shares losing 16.96%.
PRAX
HoldAug 14, 2024
Target
$48.00
Current
$162.71
Performance
217.42%
On Aug 14, 2024, Laura Chico reaffirmed PRAX with a Neutral rating, targeting 48. Market strength beyond 162.71 went further than the conservative outlook suggested.
DNLI
BuyAug 02, 2024
Target
$26.00
Current
$16.72
Performance
-23.55%
DNLI was rated Outperform by Laura Chico on Aug 02, 2024, with a price objective of 26. This case shows how bullish projections can fail, with the stock now below 16.72.
VRDN
BuyJul 29, 2024
Target
$42.00
Current
$23.01
Performance
33.08%
On Jul 29, 2024, Laura Chico initiated coverage on VRDN with a Outperform rating and target of 42. The stock’s climb of 33.08% since the call highlights the foresight in the rating.
AVTE
BuyMay 14, 2024
Target
$41.00
Current
$2.68
Performance
-99.60%
Laura Chico issued a Outperform recommendation for AVTE on May 14, 2024, price target set at 41. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.
VYGR
HoldMay 14, 2024
Target
$8.00
Current
$5.33
Performance
-37.15%
On May 14, 2024, VYGR was evaluated by Laura Chico, who gave a Neutral rating and target of 8. The Hold call avoided chasing into subsequent weakness of 37.15%.
PHVS
BuyMay 09, 2024
Target
$31.00
Current
$21.86
Performance
6.27%
Laura Chico rated PHVS as Outperform on May 09, 2024, setting a price target of 31. The call has proven timely, with shares rising 6.27% toward the price target of 31.